BD Rapid Diagnostics (Suzhou) Co Ltd, American medical technology company BD’s wholly-owned subsidiary in SIP, finished on July 28 the production of the first batch of its new antigen detection kits for detecting SARS-CoV-2, the virus causing the coronavirus disease COVID-19 that has been rampant across the world for months. The company said the new detection kit enables testing results to be given out within 15 minutes.
BD founded the subsidiary in SIP’s comprehensive bonded zone in 2006 as an arm dedicated to products and solutions for rapid infectious disease diagnosis as well as one of its major manufacturing bases worldwide. The company said the output of the new detection kits is expected to reach 2 million pieces per week by the end of September.
July 29, 2020